Top View
- T Serotypes and Antimicrobial Susceptibilities of Group A
- Therapeutic Polyanhydride Compounds for Drug Delivery
- Antibiotic Resistance Gene Resource and Assay List
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- New Treatment Options Against Gram-Negative Organisms Matteo Bassetti*, Francesca Ginocchio, Malgorzata Mikulska
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds S
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- AMR: Antimicrobial Resistance Data Analysis
- Report Name:Vietnam Phases out the Preventive Use of Antibiotics In
- Elizabeth T. Escaño-Gallardo, MD, FPPS, FPIDSP 23Rd Annual Convention Pediatric Infectious Disease Society of the Philippines February 19, 2016 Objectives
- NG198 Evidence Review G
- Literature Search Strategy for Treatment of Stable
- N=N` S N-Ch2-C-Hn J-Ch2-C-Hn S 11 N S-Ch2-C-Hn \\ / Ch-C-Hn H2
- K. Pneumoniae
- NG198 Evidence Review F1
- (12) Patent Application Publication (10) Pub. No.: US 2014/0186467 A1 DIGGS Et Al
- (12) Patent Application Publication (10) Pub. No.: US 2011/0152311 A1 Dedhiya Et Al
- WO 2U11/132171 Al
- Novel Prodrugs of Meropenem with Two Lipophilic Promoieties: Synthesis and Pharmacokinetics
- Surveillance of Healthcare-Associated Infections and Prevention Indicators in European Intensive Care Units HAI-Net ICU Protocol, Version 2.2
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Correlation of the Antimicrobial Activity of ME1036 with Its Binding Affinities to the Penicillin-Binding Proteins from Streptoc
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Penicillin Binding Proteins
- QVA149 / Indacaterol / Glycopyrronium Bromide
- (12) United States Patent (10) Patent No.: US 9.487,749 B2 Benjamin Et Al
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Critically Important Antimicrobials for Human Medicine
- Antimicrobial Peptides Against WHO-List of Critical and High-Priority Bacteria
- New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
- ARPEC Protocol for Drug Utilization Study
- Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
- Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks